Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- 1 February 2003
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 38 (2), 157-166
- https://doi.org/10.1002/jms.425
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- High-performance liquid chromatography of HIV protease inhibitors in human biological matricesJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Role of Therapeutic Drug Monitoring for Protease InhibitorsAnnals of Pharmacotherapy, 2001
- Liquid chromatographic–tandem mass spectrometric determination of amprenavir (agenerase) in serum/plasma of human immunodeficiency virus type-1 infected patients receiving combination antiretroviral therapyJournal of Chromatography A, 2001
- HIV-1 Protease InhibitorsClinical Infectious Diseases, 2000
- The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoringAIDS, 1999
- Indinavir Concentrations and Antiviral EffectPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapyAIDS, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavirAIDS, 1997